The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide

Integr Cancer Ther. 2021 Jan-Dec:20:1534735421991218. doi: 10.1177/1534735421991218.

Authors

Geliang Yang^{1

2}, Min Li¹, Huiqing Zhang³, Yufei Yang⁴

Affiliations

¹ Department of Medicine, Shanghai Clinical Research Center, Shanghai, China.
² Department of Traditional Chinese Medicine, the Second Medical Center, Chinese PLA General Hospital, Beijing, China.
³ Department of Traditional Chinese Medicine, Naval Medical University, Shanghai, China.
⁴ Department of Oncology Diagnosis and Treatment, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / epidemiology*
Clinical Trials as Topic / methods
Humans
Integrative Oncology / methods
Neoplasms / drug therapy*
Neoplasms / therapy*
Pandemics
SARS-CoV-2 / isolation & purification